Download Sample
Schedule a Meeting
NA : +1 804 441 9344
sales@towardshealthcare.com
October 2025
The global travel vaccination service market size is calculated at USD 4.69 billion in 2024, grew to USD 5.15 billion in 2025, and is projected to reach around USD 11.99 billion by 2034. The market is expanding at a CAGR of 9.85% between 2025 and 2034.
The travel vaccination service market is primarily driven by the increasing international tourism and growing awareness of the importance of vaccinations. Healthcare organizations provide tailored advice based on the destination, delivering appropriate vaccines. Government organizations conduct campaigns to create awareness about preventing the spread of disease in their respective nations. Artificial intelligence (AI) helps analyze a patient and provide information on necessary vaccinations based on a traveler’s destination.
| Table | Scope |
| Market Size in 2025 | USD 5.15 Billion |
| Projected Market Size in 2034 | USD 11.99 Billion |
| CAGR (2025 - 2034) | 9.85% |
| Leading Region | North America by 38% |
| Market Segmentation | By Service Type/Offering, By Vaccine Type Administered, By Customer/Traveler Type, By Business Model/Payer Mix, By Region |
| Top Key Players | GeoBlue Travel Insurance, CVS Minute Clinic, KlinikTravel, Expedia, Bupa Global, Cigna Global, International Travel Health & Vaccine Clinic, Vernova Healthcare CIC, Advocate Healthcare, Travel Medicine & Vaccination Center, Walgreens |
The travel vaccination service market is driven by international tourism and business travel volumes, increasing traveler awareness of vaccine-preventable diseases, regulatory or entry requirements (e.g., yellow fever), corporate travel health programs, and expansion of point-of-care vaccination channels (retail pharmacies, occupational health). It comprises clinical services, clinics, pharmacies, and mobile/outreach programs that provide pre-travel consultation and immunizations to international travelers. Services include risk assessment, vaccine administration (routine and travel-specific vaccines), vaccine record management (proof of vaccination/Yellow Card), travel health counseling, prophylactic medications (e.g., malaria chemoprophylaxis), and post-travel follow-up.
The use of AI in travel vaccination services is still in its infancy; however, numerous professionals have implemented it for more personalized services. AI and machine learning (ML) algorithms can analyze patient data and study the incidence of a disease in a specific country, suggesting vaccinations to patients. AI and natural language programming (NLP) understand patients’ concerns and remove language barriers. Additionally, AI and ML analyze real-time data about a person’s health, destination, and lifestyle preferences.
In September 2025, the World Health Organization (WHO) released the “International Travel and Health: Module 4: Vaccine-Preventable Diseases and Vaccines” to educate health authorities who support travel health professionals in their jurisdiction or develop health advice for their population. The module also benefits travelers, travel agents, and shipping companies.
The Government of Canada, through its Public Health Agency of Canada, provides the Canadian Immunization Guide. It offers detailed information about immunization for travelers, including children, infants, and adults.
In Germany, the Standing Committee on Vaccination (STIKO) prepares vaccination recommendations and specific prevention measures for children, adolescents, and adults, considering the benefits both to those vaccinated and the population as a whole.
By service type/offering, the on-site clinic & travel health centers segment held a dominant presence in the market with a share of approximately 40% in 2024, due to the availability of skilled professionals and favorable ambience. Travel health centers possess appropriate diagnostic products and vaccinations to provide personalized services. Travel health professionals can perform a physical examination of a patient and facilitate face-to-face communication. Non-verbal cues and body language can significantly enhance communication.
By service type/offering, the telemedicine/virtual pre-travel consultation segment is expected to grow at the fastest CAGR in the market during the forecast period. Telemedicine is more affordable than in-person visits, saving travel time and costs. Patients can reach out to experts around the globe through video conferencing. According to a recent U.S. national survey, about 67% of 2080 participants were willing to use video consultations, potentiating the growth of telemedicine.
By vaccine type administered, the routine & core travel vaccines segment held the largest revenue share of approximately 38% in the market in 2024, due to the high chances of developing common diseases and growing awareness about regular vaccinations. Government organizations provide guidelines related to administering routine vaccines, such as COVID-19, flu, and Tdap (tetanus, diphtheria, and whooping cough). These vaccines are highly recommended to people who are at high risk of developing diseases, such as older people, people with heart disease and other chronic conditions, and those who are immunodeficient.
By vaccine type administered, the others/new travel vaccines segment is expected to grow with the highest CAGR in the market during the studied years. Researchers develop novel vaccines to help patients fight mutated/resistant pathogen strains. Regulatory agencies approve novel vaccines to prevent people from developing diseases like chikungunya, tick-borne encephalitis, and COVID-19.
By customer/traveler type, the leisure travelers & tourists segment contributed the biggest revenue share of approximately 48% in the market in 2024, due to rising disposable incomes and favorable planned traveling. The burgeoning medical tourism sector encourages people to travel to foreign countries. The UN Tourism’s World Tourism Barometer reported that an estimated 1.4 billion tourists traveled internationally in 2024. Boston Consulting Group projected that leisure travel will present $15 trillion opportunity for airlines, hotels, and other travel industry stakeholders in 2040.
By customer/traveler type, the expatriates/long-term travelers segment is expected to expand rapidly in the market in the coming years. Long-term travelers and expatriates need vaccines to prevent themselves from coming into contact with potential diseases. The availability of travel insurance that covers health and emergency evacuation, especially from remote areas, boosts the segment’s growth. Travel vaccines to protect against disease endemic to their destination and meet country requirements.
By business model/payer mix, the out-of-pocket/direct payment segment led the market with a share of approximately 54% in 2024, due to the availability of cost-effective routine vaccines. Travelers pay out-of-pocket for pre-travel care because of limited health insurance plans for travel immunizations and prophylactic medications. This is because travel vaccines are considered non-essential by insurance companies, and they are tailored to a traveler’s specific itinerary.
By business model/payer mix, the travel agency/tour operator bundles segment is expected to witness the fastest growth in the market over the forecast period. Several travel agencies offer a complete package for travel from pre-travel consultations to post-travel services. Patients directly pay for their packages, which include vaccinations, risk assessment, ticketing charges, and accommodation.
North America dominated the global market with a share of approximately 38% in 2024. The increasing number of people traveling from and to North American countries and favorable government support are the major growth factors of the market in North America. Government organizations provide guidelines about routine and specialized vaccinations for travelers. The increasing investments and the availability of a robust healthcare infrastructure augment the market. The growing number of primary health centers or clinics increases accessibility to travel vaccines among a wide range of the population.
Passport Health, Superdrug Health Clinic, and Concentra are certain clinics that offer travel vaccination services in the U.S. Passport Health, alone, operates over 270 clinics across the U.S. Approximately three-quarters of Americans (76%) have visited at least one other country, of which 26% have visited more than five countries. The Centers for Disease Control and Prevention (CDC) recommends travelers get vaccinated against measles and other diseases before traveling to any country.
Statistics Canada reported that Canadian residents’ international trips rose from 26.9% of all trips in April 2024 to 36.1% in 2025. In 2024, approximately 39 million Canadians travelled to the U.S., representing 75% of all international trips.Travel Vaccination & TB Testing Clinic, PC Health, and Travel Medicine & Vaccination Center are the major travel vaccination centers in Canada.
Asia-Pacific is expected to grow at the fastest CAGR in the market during the forecast period. The burgeoning healthcare sector and the emerging health insurance companies propel the market. People are becoming aware of immunizations and risk assessment before traveling through several campaigns and advertisements. The rapidly expanding middle-class population and the increasing disposable incomes are fostering market growth. Asia-Pacific countries, such as Thailand, Myanmar, and India, offer excellent medical tourism services, resulting in a surge in travelers to these countries.
Thailand is the most preferred destination in Asia for medical tourism, attracting millions of people from all over the world. More than 34 million people visited Thailand in 2024. People visiting Thailand are at high risk of infectious diseases, including rabies, enteric infections, respiratory infections, and waterborne diseases. Thai Travel Clinic, Bumrungrad International Hospital, Samitivej Hospital, and BNH Hospital provide tailored travel vaccination services in Thailand.
In the first half of 2024, 15 million Indians traveled internationally, accounting for a 14% year-on-year increase. This is supported by rising disposable incomes. Indian travelers spend up to $7,000 on international trips, and overseas spending by Indians reached $31.7 billion in the fiscal year 2024, an increase of 25% from 2023.To address travel vaccination demand, the Indian government has set up yellow fever vaccination centers, accounting for a total of 72 centers across the nation.
| Companies | Headquarters | Offerings |
| Passport Health | United States | It is a leading provider of travel health and corporate wellness services with over 300 locations in the U.S., Canada, Mexico, and the UK. |
| LloydsPharmacy | United Kingdom | It provides personalized travel advice on all things from malaria tablets to suncare and vaccinations. |
| Woodlands Health Campus | Singapore | The Vaccination and Travel Clinic (VTC) provides a comprehensive range of vaccinations and travel health services. |
| Masta Travel | United Kingdom | It offers specialized travel health consultations, vaccinations, antimalarials, and travel-related retail items. It has 100+ clinics nationwide and served 1.5 million patient visits. |
| ViTravel (Vancouver Island Travel Clinic) | Canada | ViTravel offers vaccinations, TB test services, and first aid supplies, assisting with healthful travel planning and addressing all travel needs. |
By Service Type/Offering
By Vaccine Type Administered
By Customer/Traveler Type
By Business Model/Payer Mix
By Region
October 2025
October 2025
October 2025
September 2025